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Healthcare workers (HCWs) are considered to run a higher occupational risk of becoming infected with severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2), and develop coronavirus disease (COVID-19) than the rest of the 
population. The aim of this study was to describe and analyse the characteristics of work-related COVID-19 in Croatian 
HCWs. Study participants were HCWs who contacted their occupational physician between 1 May 2020 and 12 November 
2020 with a request for the registration of COVID-19 as an occupational disease. All participants filled out our online 
Occupational COVID-19 in Healthcare Workers Questionnaire. The study included 59 HCWs (median age 45.0, interquartile 
range 36.0–56.0 years). Most (78 %) were nurses or laboratory technicians, and almost all (94.9 %) worked in hospitals. 
Hierarchical cluster analysis revealed three clusters of COVID-19-related symptoms: 1) elevated body temperature with 
general weakness and fatigue, 2) diarrhoea, and 3) headache, muscle and joint pain, anosmia, ageusia, and respiratory 
symptoms (nasal symptoms, burning throat, cough, dyspnoea, tachypnoea). Almost half (44.6 %) reported comorbidities. 
Only those with chronic pulmonary conditions were more often hospitalised than those without respiratory disorders 
(57.1 % vs. 2.5 %, respectively; P=0.001). Our findings suggest that work-related COVID-19 among Croatian HCWs is 
most common in hospital nurses/laboratory technicians and takes a mild form, with symptoms clustering around three 
clinical phenotypes: general symptoms of acute infection, specific symptoms including neurological (anosmia, ageusia) 
and respiratory symptoms, and diarrhoea as a separate symptom. They also support evidence from other studies that 
persons with chronic pulmonary conditions are at higher risk for developing severe forms of COVID-19.
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Working in healthcare during the coronavirus disease 
(COVID-19) pandemic, presents a great challenge in many 
respects and brings a high risk of infection with severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) due to 
direct or indirect everyday contact with infected people 
(patients and colleagues) (1–3). Recent literature suggests 
that healthcare workers (HCWs) in emergency/acute 
medicine departments are at an even higher risk of SARS-
CoV-2 infection than the rest, including those in intensive 
care units (4, 5). In addition, HCWs working in COVID-19 
wards have a higher prevalence of antibodies against SARS-
CoV-2 than other frontline HCWs working in hospitals (6). 
Nurses seem to be more often infected and having 
COVID-19 than physicians (4).
HCWs who are suffering from common comorbidities, 
such as hypertension, chronic obstructive pulmonary 
disease, and diabetes are exposed to an even greater risk of 
SARS-CoV-2 infection (7). Such comorbidities are more 
often present in older workers, who are therefore more prone 
to develop severe forms of COVID-19 that require 
hospitalisation, such as pneumonia (8).
Data about the COVID-19 in Croatian HCWs are scarce, 
and the aim of this preliminary study was to analyse the 
characteristics of work-related COVID-19 in Croatian 
HCWs.
PARTICIPANTS AND METHODS
This study included 59 Croatian HCWs from eight of 
the twenty-one Croatian counties, aged 18 to 65 years, who 
tested SARS-CoV-2-positive and contacted their 
occupational physician to have their COVID-19 registered 
as occupational disease between 1 May 2020 and 12 
November 2020. Occupational physicians assessed 
workplace risk by taking patient’s occupational history and 
suggested participation in the study if they tested SARS-
CoV-2 positive.
The study was approved by the Ethics Committees of 
Zagreb University School of Medicine and the Institute for 
Medical Research and Occupational Health, Zagreb. All 
participants signed an informed consent.
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Occupational physicians who collaborated in this study 
familiarised participating HCWs, who were their patients, 
with our online Occupational COVID-19 in Healthcare 
Workers Questionnaire. We compiled this questionnaire in 
Microsoft Forms® and sent the link to occupational 
physicians via e-mail. The physicians forwarded the link 
to their patients. The questionnaire starts with a short study 
description and continues with multiple choice questions 
about comorbidities, symptoms during the isolation (general 
weakness and fatigue, elevated body temperature, decreased 
sense of smell and taste, nasal congestion and fusion of 
postnasal secretion, cough and burning throat, severe 
respiratory symptoms, headache, muscle and joint pain, 
diarrhoea), and hospitalisation due to COVID-19. The 
participants were also asked to fill in their name, family 
name, age, personal identification number, gender, and 
employment info in a healthcare institution at the end of 
the questionnaire.
Statistical analysis
Beside the methods of descriptive statistics, 
characteristics and differences between hospitalised and 
non-hospitalised HCWs infected with SARS-CoV-2 were 
analysed with Fisher’s exact test (for categorical variables) 
and Mann-Whitney U test (for continuous variables). 
Continuous data were represented as medians, while 
categorical data were represented as counts and percentages. 
Hierarchical cluster analysis (HCA) was used as the primary 
statistical method for COVID-19 related symptoms, which 
were coded as a binary variable (1=with symptoms and 
0=without symptoms), to find relatively homogeneous 
clusters of symptoms based on measured characteristics 
among participants. HCA starts with each symptom as a 
separate cluster, and then combines clusters sequentially, 
reducing the number of clusters at each step, until only one 
cluster remains. We used the nearest neighbour as a 
clustering method to assess dissimilarities or distances 
between variables. The distance between two clusters is 
defined as the smallest distance between two cases in 
different clusters. As a distance measure between the 
clusters we used the squared Euclidean distance, as it places 
greater emphasis on objects that are further apart. All P 
values below 0.05 were considered significant. All statistics 
was run on IBM SPSS Statistics for Windows, version 25.0 
(IBM Corp., Armonk, NY, USA).
RESULTS
The general characteristics of the study participants and 
the most reported comorbidities are shown in Table 1. Most 
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Table 1 General characteristics of study participants (N=59) 
 N %
Job





Age (years) Median (IQR) 45.0 (36.0–56.0)
Type of healthcare institution (affiliation)
Health centre 3 5.1
General county hospital 22 37.3
Clinical hospital 7 11.9






















*Crohn’s disease, hypothyroidism, Hashimoto’s thyroiditis, Lupus erythematosus. IQR – interquartile range
38
(78 %) were nurses or laboratory technicians, and most 
(94.9 %) worked in hospitals.
Table 2 shows the self-reported occurrence of 
COVID-19 related symptoms, the most common of which 
were general weakness and fatigue (66.1 %), elevated body 
temperature (57.6 %), and impaired/lost sense of smell 
(40.7 %). The final cluster interpretation of agglomeration 
schedule and coefficient changes came up with three 
clinically significant clusters (cluster determination line 
between 20 and 25 squared Euclidean distance): 1) elevated 
body temperature with general weakness and fatigue, 2) 
diarrhoea, and 3) all other symptoms (Figure 1).
Valid responses about hospitalisation were given by 47 
(79.6 %) participants, only seven of whom (14.9 %) were 
hospitalised. Hospitalised and non-hospitalised participants 
did not differ significantly in the age, job, gender, type of 
health care institution, or total number of comorbidities. 
However, significantly more participants with respiratory 
comorbidity (asthma and chronic obstructive pulmonary 
disease) were hospitalised than not (four of seven 
hospitalised or 57.1 % vs. one of forty non-hospitalised or 
2.5 %, respectively; P=0.001). Such significant difference 
was not found for any other comorbidity (listed in Table 1). 
Differences in COVID-19 related self-reported symptoms 
between hospitalised and non-hospitalized HCWs were not 
significant, except for cough, which was more prevalent 
among hospitalised than non-hospitalized patients (five of 
seven or 71.4 % vs. six of forty or 15.0 %, respectively; 
P=0.015).
DISCUSSION
Most of our participants reported mild symptoms and 
did not need hospitalisation. Considering their age (median 
45 years; IQR 36–56 years), this was quite expected. Misra-
Hebert et al. (9) reported that younger HCWs who are 
directly exposed to COVID-19 patients have higher odds 
to test positive to SARS-CoV-2 but lower odds to be 
hospitalised over COVID-19. The median age of HCWs in 
that study was 39.7 years, which is similar to ours. However, 
these data are not entirely comparable, since their sample 
was over 6000 HCWs and we did not have full data about 
hospitalisations (12 participants did not answer that 
question).
Nearly half of our participants (44.6 %) reported chronic 
comorbidities, but two thirds of them reported hypertension, 
which was not found as a risk factor for severe symptoms 
leading to hospitalisation. Other comorbidities were rare. 
Participants with chronic pulmonary condition (chronic 
obstructive pulmonary disease and asthma) needed hospital 
treatment in significantly higher proportion than participants 
without such comorbidity. In line with that, our hospitalised 
participants reported cough significantly more often than 
non-hospitalised ones. These findings support evidence that 
persons with chronic pulmonary conditions are at a higher 
risk of developing severe forms of COVID-19 (10) and are 
important for assessing work ability in people with chronic 
pulmonary disorders whose workplaces involve high risk 
of SARS-CoV-2 infection. In such cases a temporary change 
of workplace should be considered, particularly if 
pulmonary disorder compromises the use of personal 
protective equipment.
We found three significant clusters of COVID-19 related 
symptoms in our participants. The first cluster includes 
weakness, fatigue, and elevated body temperature, which 
are common general symptoms of acute infection. The 
second cluster seems to be more COVID-19 specific with 
a combination of headache, muscle and joint pain, anosmia, 
ageusia, and respiratory symptoms (nasal secretion and 
congestion, burning throat, cough, shortness of breath, 
dyspnoea at rest, tachypnoea). The third cluster is diarrhoea 
alone, which points to a separate form of disease in line 
with other studies. Dixon et al. (11) found two clusters: one 
included ageusia, anosmia, and fever, the other cough, 
shortness of breath, and chest pain. Wise (12) found six 
clusters: flu-like with no fever, flu like with fever, 
gastrointestinal symptoms, and three clusters separating 
three levels of severe disease. Clusters obviously overlap 
between studies, but it is evident that gastrointestinal 
symptoms are either not there or make a separate cluster. 
We believe that these differences in the number of clusters 
is owed not only to the type and frequency of symptom 
reporting, but also to the choice of statistical methods in 
cluster determination. Anosmia is common among SARS-
CoV-2 infected HCWs and is a strong predictor of infection 
(13). Anosmia and ageusia were reported by 30–40 % of 
infected hospital workers in Milan, Italy (14), which is 
consistent with our findings.
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Table 2 COVID-19 related self-reported symptoms among HCWs 
(N=59)
Symptoms N %
General weakness and fatigue 39 66.1
Elevated body temperature 34 57.6
Decreased sense of smell 24 40.7
Muscle pain 23 38.9
Nasal congestion 21 35.6
Decreased sense of taste 19 32.2
Diarrhoea 18 30.5
Severe respiratory symptoms* 18 30.5
Joint pain 18 30.5
Fusion of postnasal secretion 16 27.1
Cough 11 18.6
Burning throat 11 18.6
Headache 8 13.6
*severe respiratory symptoms: shortness of breath, tachypnoea, 
dyspnoea in rest
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In line with other studies (4), we noticed that significantly 
more hospital nurses and laboratory technicians reported 
COVID-19 than physicians. These findings probably 
suggest a higher risk of infection among nurses. Regression 
analysis of mortality rates by countries and professions in 
one study (15) revealed that nurses got more often infected 
with SARS-CoV-2 and ran a significantly higher risk of 
death than physicians in Italy, Spain, France, and Brazil.
We also noticed that of all our participants who 
requested that their COVID-19 is acknowledged as 
occupational 95 % work in hospitals and only 5 % in 
primary healthcare. This is probably because in the 
pandemic conditions primary care HCWs have limited their 
contact with patients suspect of SARS-CoV-2 infection 
primarily to telephone or e-mail communication.
Limitations
This study analyses preliminary data from an ongoing 
investigation that only includes participants claiming the 
acknowledgement of occupational disease. It is also limited 
to self-reported information and has no access to medical 
documentation. We had no exact information on the 
availability of personal protective equipment and the 
behaviour of HCWs in hospitals, which could explain the 
observed difference in infection between nurses and other 
HCWs.
CONCLUSION
Work-related COVID-19 among Croatian HCWs is 
most common in hospital nurses/laboratory technicians and 
takes a mild form with no need for hospital treatment. Our 
findings support evidence that persons with chronic 
pulmonary conditions are at a higher risk of developing 
severe forms of COVID-19. Symptom clustering points to 
three different clinical phenotypes: general symptoms of 
acute infection, COVID-19 specific neurological (anosmia, 
ageusia) and respiratory symptoms, and diarrhoea as a 
separate symptom. Further cluster analysis will involve a 
larger sample in order to investigate differences in 
symptoms between hospitalised and non-hospitalised 
HCWs.
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Figure 1 Clustering of symptoms reported by HCWs (N=59): blue – COVID-19 neurological, musculoskeletal, and respiratory 
symptoms; yellow – gastrointestinal symptom; red – acute infection symptoms. *shortness of breath, tachypnoea, dyspnoea in rest
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Karakteristike COVIDA-19 vezanog uz rad hrvatskih zdravstvenih djelatnika ‒ preliminarna studija
Smatra se da zdravstveni radnici imaju povećan rizik od infekcije koronavirusom teškog akutnog respiratornog sindroma 
2 i od koronavirusne bolesti (COVID-19) na radnom mjestu u odnosu na ostatak populacije. Cilj je ove studije opisati i 
analizirati karakteristike COVIDA-19 vezanog uz rad hrvatskih zdravstvenih radnika. Ispitanici su zdravstveni radnici 
koji su kontaktirali nadležnog specijalista medicine rada od 1. svibnja do 12. studenoga 2020. sa zahtjevom da im se 
COVID-19 registrira kao profesionalna bolest. Svi ispitanici ispunili su virtualni obrazac upitnika “Profesionalna bolest 
COVID-19 u zdravstvenih radnika”, koji su osmislili autori studije. U studiju je uključeno 59 zdravstvenih radnika 
(medijan dobi 45,0; interkvartilni raspon 36,0‒56,0 godina). Većinu ispitanika činile su medicinske sestre/tehničari (78 %), 
a gotovo svi su radili u bolnicama (94,9 %). Hijerarhijskom klasterskom analizom razdvojena su tri klastera simptoma 
koronavirusne bolesti: 1) vrućica, opća slabost i umor, 2) proljev i 3) glavobolja, bolovi u mišićima i zglobovima, anosmija, 
ageuzija, dišni simptomi (nazalni simptomi, žarenje grla, kašalj, dispneja, tahipneja). Gotovo polovina ispitanika (44,6 %) 
prijavila je komorbiditete. Samo oni s kroničnim plućnim poremećajima bili su češće hospitalizirani od ispitanika bez 
plućnih poremećaja (57,1 % vs. 2,5 %; P=0,001). Zaključno, COVID-19 vezan uz rad u hrvatskih zdravstvenih radnika 
najčešće se prezentira u bolničkih medicinskih sestara/tehničara kao blagi oblik bolesti. Rezultati potvrđuju tvrdnje da 
osobe s kroničnim plućnim poremećajima imaju veći rizik od težih oblika COVIDA-19. Klasterska analiza simptoma 
upućuje na tri klinička fenotipa koronavirusne bolesti: opće simptome akutne infekcije, specifične simptome koji uključuju 
anosmiju, ageuziju i dišne simptome te gastrointestinalni oblik bolesti.
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